JAMA Editor Should Apologize & Resign
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
Seroquel Victim Asked Judge to Unseal Documents
Why is FDA Silent? Seroquel Victim Asked Judge to Unseal Documents for FDA Advisory
Obama picks Duo to Run FDA: Dr Hamburg, Commissioner; Dr. Sharfstein Deputy
Dr. Margaret "Peggy" Hamburg, a former health commissioner in New York City, is the leading candidate to become FDA commissioner, the agency's top job, while Baltimore health chief Joshua Sharfstein is in line to become a deputy commissioner
Two Cases of Massive Fraud–Anesthesiology–Psychiatry
Two major cases of medical fraud have undermined patient safety and the integrity of the medico-scientific literature: But how each specialty responded is a study in contrast.
Psychiatrists On the Take: the Focus of Government Investigations
Two prominent academic-psychiatrists–Jeffrey Bostic MD, director of school psychiatry, Harvard-Massachusetts General Hospital, and Charles Nemeroff MD, the former chairman of psychiatry at Emory–are featured in current government investigations.
Lawsuit Charges Medscape CME With Off-Label Promotion Scheme
New revelations in an unsealed whistleblower-initiated lawsuit filed in Boston add yet another dimension to the scope and magnitude of corruption that has derailed American medicine–the focus is tainted Continuing Medical Education.
AstraZeneca: “Smoke-and-Mirror Jobâ€
The unsealed documents reveal that AstraZeneca “buried” unfavorable studies that showed Seroquel posed a serious risk for diabetes.
RE: Stimulus Funding to Compare Treatments_Scientific American
AHRP Quoted in Scientific American
Rolling Stone – Marketing a Phony “Miracle” Drug
“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
Biederman J & J Risperdal Documents
A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
Vera Sharav: A Profile in Nature Biotechnology
Dr. Marcia Angell, a senior lecturer at Harvard Medical School, and former editor of the New England Journal of Medicine and author of The Truth About Drug Companies, describes Sharav as an extraordinarily observant and valuable critic. "I see her as someone the research establishment badly needs."
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.